Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

TridentCare Announces Acquisition of DispatchHealth's Imaging Business Unit
Healthcare & PharmaceuticalMergers and Acquisitions

TridentCare Announces Acquisition of DispatchHealth's Imaging Business Unit

January 21, 2026 11:30 AM

TridentCare, the nation's leading provider of portable diagnostic services, announced its acquisition of DispatchHealth's imaging business unit, effective January 20, 2026. This strategic transaction underscores TridentCare's commitment to advancing in-home care, broadening market presence, and delivering exceptional service to patients and providers nationwide. The Imaging division of DispatchHealth operates across 16 states, offering portable...

Read more
Dr. Nikesh Seth Calls for a More Human Approach to Pain Care
Healthcare & PharmaceuticalCompany Update

Dr. Nikesh Seth Calls for a More Human Approach to Pain Care

January 21, 2026 11:05 AM

Dr. Nikesh Seth, a board-certified anesthesiologist and interventional pain management physician, is calling on patients and healthcare providers alike to rethink how chronic pain is treated-placing empathy, innovation, and informed choice at the center of care. With more than 15 years of clinical experience, Dr. Seth is raising awareness about the need for individualized, minimally invasive approaches that go beyond symptom management to focus...

Read more
Curiteva Surpasses More Than 10,000 Levels Successfully Treated
Healthcare & PharmaceuticalCompany Update

Curiteva Surpasses More Than 10,000 Levels Successfully Treated

January 21, 2026 9:30 AM

Curiteva, Inc., a privately held, technology and manufacturing company, is proud to announce the significant achievement of over 10,000 levels successfully treated using the Inspire implant portfolio. With 5,000 interbodies implanted in just the last several months, this milestone underscores the rapid market adoption and transformative impact of the company's novel 3D-printed Trabecular PEEK with HAFUSEtechnology. This achievement coincides...

Read more
Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC Pink:MDCE) Completes Marketing Content for First AI-Based Lifestyle App Ahead of Imminent Launch

January 21, 2026 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) ("Medical Care Technologies" or the "Company"), a developer of AI-driven lifestyle, wellness, and medical pre-screening mobile applications, today provided a corporate update highlighting a major milestone in preparation for its first consumer app launch. The Company has successfully completed the creation of its full social media and digital marketing campaign content for its first AI-based...

Read more
EDGE Surgical Signs Agreement with 3Di Medical to Accelerate Adoption of Ortho EDG(R) Across Florida Hospitals
Healthcare & PharmaceuticalPartnerships

EDGE Surgical Signs Agreement with 3Di Medical to Accelerate Adoption of Ortho EDG(R) Across Florida Hospitals

January 21, 2026 9:00 AM

EDGE Surgical, Inc., the innovative brand behind the world's only electronic depth gauge for orthopedic surgery, today announced a $225,000 agreement appointing 3Di Medical as an authorized distributor for the Ortho EDG® Universal Electronic Depth Gauge in Florida. This relationship comes at a critical juncture, propelled by the rapidly growing demand for the Ortho EDG®. Integral to the EDGE Surgical commercialization efforts, 3Di Medical will...

Read more
Alpha Genesis Announces Research Animal Retirement and Lifetime Care Program to Preserve Animal Welfare, Research Continuity, and National Preparedness
Healthcare & PharmaceuticalCompany Update

Alpha Genesis Announces Research Animal Retirement and Lifetime Care Program to Preserve Animal Welfare, Research Continuity, and National Preparedness

January 21, 2026 9:00 AM

Alpha Genesis Inc., the largest nonhuman primate breeding and research services organization in the United States, today announced the expansion of its long-term research animal retirement and lifetime care services. The program is designed to provide dignified, humane, and fiscally responsible lifelong care for nonhuman primates that have completed participation in biomedical research. The announcement comes as multiple National Primate...

Read more
New Year, New Feet: Simple Steps to Healthier Feet in 2026
Healthcare & PharmaceuticalCompany Update

New Year, New Feet: Simple Steps to Healthier Feet in 2026

January 21, 2026 9:00 AM

As people across the country set health goals for the new year, foot health is often overlooked-yet it plays a critical role in overall wellness, mobility, and quality of life. To help patients start 2026 on the right foot, Ankle & Foot Centers of America is sharing simple, practical habits anyone can begin this January to support healthier feet all year long. "Your feet are the foundation of your body," explains a podiatry specialist with Ankle...

Read more
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Healthcare & PharmaceuticalCompany Update

Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI

January 21, 2026 8:30 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation, announced that the Company has reached agreement with the FDA on an approval pathway for Gemini as a treatment for Acute Kidney Injury (AKI). The two key agreements were 1) a clinically relevant and objective composite endpoint comprising death and/or need for dialysis, and 2) positive...

Read more
Ensysce Biosciences Expands Global Opioid Patent Portfolio
Healthcare & PharmaceuticalProduct Announcements

Ensysce Biosciences Expands Global Opioid Patent Portfolio

January 21, 2026 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today announced it received a Notice of Allowance from the Brazilian Patent Office for the issuance of a patent* covering additional opioid families, utilizing the Company's proprietary TAAP™ (Trypsin Activated Abuse Protection)...

Read more
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign
Healthcare & PharmaceuticalProduct Announcements

Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign

January 21, 2026 8:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending delivery technology, is proud to announce the launch of a comprehensive brand redesign for its flagship caffeine product, BUZZ BOMB™. This strategic rebranding initiative introduces a new logo, sleek, modern website and eye-catching product packaging, reflecting the product's capabilities and Aspire...

Read more
The Holy Grail of Cardiology Has Arrived
Healthcare & PharmaceuticalProduct Announcements

The Holy Grail of Cardiology Has Arrived

January 21, 2026 7:40 AM

Today marks one of the most profound moments in the history of cardiovascular medicine. A newly published, peer-reviewed multi-center retrospective case series has delivered irrefutable evidence that high-viscosity 2-Hydroxypropyl-β-cyclodextrin (Cavadex) can reverse established coronary artery calcification, a biological outcome long considered impossible. Published Paper: Longitudinal Retrospective Analysis of High-Viscosity...

Read more
enBio Appoints Robert Lewis to Advisory Board Effective January 21
Healthcare & PharmaceuticalCompany Update

enBio Appoints Robert Lewis to Advisory Board Effective January 21

January 21, 2026 7:00 AM

enBio Corp., a rapidly growing provider of biomedical, hospital bed management, and HTM services, today announced the appointment of Robert Lewis to its Advisory Board, effective January 21. Robert Lewis brings more than three decades of senior leadership experience in healthcare sales, market development, and capital equipment strategy. Most recently, he served as Regional Sales Leader for Life Care Solutions at GE Healthcare, where he led...

Read more
Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company
Healthcare & PharmaceuticalManagement Changes

Ascelia Pharma Announces Deputy CEO Julie Waras Brogren to Leave the Company

January 21, 2026 5:00 AM

Ascelia Pharma AB (publ) (STO:ACE) today announced that Deputy CEO Julie Waras Brogren will leave the company to take up a CEO position in another company. Julie Waras Brogren joined Ascelia Pharma in January 2020 as CCO and became Deputy CEO in October 2022. Since August 2023, she has also held the role of CFO. Magnus Corfitzen, CEO of Ascelia Pharma, said: "I want to thank Julie for her dedication to Ascelia Pharma. She has been instrumental...

Read more
Senzime Secures Major Ivy League US Hospital System Contract
Healthcare & PharmaceuticalCompany Update

Senzime Secures Major Ivy League US Hospital System Contract

January 21, 2026 3:50 AM

Senzime AB (STO:SEZI)(OTCQX:SNZZF) today announced that it has secured another strategic contract in the US with a leading Ivy League university hospital system. The contract includes in its first phase an installation of 60 next-generation TetraGraph systems, and annual usage from these monitors are expected to exceed 10,000 disposable sensors at full implementation. "We are continuing to convert operating room after operating room with our...

Read more
iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users
Healthcare & PharmaceuticalCompany Update

iZafe Group Launches Modular Display and Remote Care System - One Dosell for All Users

January 21, 2026 3:15 AM

iZafe Group AB ("Company")(STO:IZAFE-B) today launches an external Display for Dosell together with a new remote care system featuring a web interface and mobile app. The launch takes place in connection with the MVTe trade fair, which starts today, where Dosell is exhibiting at booth I24. The new solution means that healthcare providers no longer need to choose between simpler or more advanced medication dispensing devices - the same Dosell can...

Read more
BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)
Healthcare & PharmaceuticalCompany Update

BioNxt Reports Final Preclinical Results Demonstrating Approximately 40% Higher Cladribine Delivery for the Treatment Multiple Sclerosis (MS)

January 21, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to report final results from a preclinical pig study demonstrating that its proprietary needle-free, swallow-free sublingual oral dissolvable film (ODF) cladribine formulation for the treatment of Multiple Sclerosis (MS) achieved significantly higher systemic drug delivery than a conventional oral tablet formulation of cladribine, such as those used in...

Read more
SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions
Healthcare & PharmaceuticalCompany Update

SoftWriters Strengthens Leadership Team with Addition of LiAna Tschen and Strategic Role Expansions

January 21, 2026 2:00 AM

SoftWriters, the leading provider of pharmacy management software for long-term care (LTC) pharmacies, today announced continued strategic investments to strengthen organizational depth and expand its platform and services. These investments are highlighted by the addition of LiAna Tschen as Vice President, Platform Operations, along with key leadership advancements that reinforce SoftWriters' commitment to innovation, operational excellence,...

Read more
Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners
Healthcare & PharmaceuticalCompany Update

Dispense Times Releases New Issue Featuring Mark Cuban, Offering Clarity for Independent Pharmacy Owners

January 21, 2026 12:00 AM

Dispense Times, a leading digital publication serving independent pharmacy owners across the United States, has released its latest January-February issue, featuring an in-depth article with Mark Cuban that helps clear up widespread misconceptions surrounding Cost Plus Drugs and its role within the pharmacy ecosystem. As conversations around alternative drug pricing models continue to gain attention, this issue was developed to provide pharmacy...

Read more
Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference
Healthcare & PharmaceuticalConferences

Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference

January 20, 2026 5:50 PM

Tivic Health® Systems, Inc. (NASDAQ:TIVC), a late-stage immunotherapeutics company, today announced that its CEO will provide a corporate update focused on recent developments in its advancement of Entolimod ™ during the Emerging Growth Virtual Conference on January 21 and 22, 2026 WHO: Jennifer Ernst, Chief Executive Officer WHERE: January 22, 2026 WHEN: 4:10 - 4:20 Eastern Time During the virtual conference update, Ms. Ernst will highlight...

Read more
Aytu BioPharma Recaps Investor Day Held on January 20, 2026
Healthcare & PharmaceuticalConferences

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

January 20, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today provided a summary of the Company's Investor Day, held today, Tuesday, January 20, 2026, at 11:00 a.m. Eastern time in New York City. The Investor Day was conducted both in-person and via webcast. A replay of the event can be...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?